Shanghai Haohai Biological Technology Co Ltd banner

Intrinsic Value

The intrinsic value of Shanghai Haohai Biological Technology Co Ltd (5HB) under the Base Case is 2.56 EUR per share. Compared with the current market price of 1.79 EUR, the stock appears Undervalued by 30% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

5HB Intrinsic Value
€2.56
Undervaluation 30%
Intrinsic Value
Price €1.79
Alert me when 5HB is below its intrinsic value
Today €1.54 · 14.1% below the current price

5HB is cheaper than usual. It was this cheap or cheaper on just 8% of days in the past 5 years.

Alternatives to 5HB

Fundamental Analysis

What Shanghai Haohai Biological Technology Does

Biotechnology Health Care

Shanghai Haohai Biological Technology makes medical biomaterials and related products used in hospitals and clinics. Its core business is eye care, where it sells products used in eye surgery and other ophthalmic treatments. It also has products for surgical anti-adhesion, wound care, and medical aesthetics, such as injectable materials used by doctors in cosmetic procedures.

Headquarters
China CN
Employees
2 110
IPO date
Apr 30, 2015
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue 5HB Research

Decided on Shanghai Haohai Biological Technology? Get an email when 5HB reaches the price you’d buy at. Free with an account.

Other Shanghai Haohai Biological Technology listings

What is the Intrinsic Value of one 5HB stock?

The intrinsic value for Shanghai Haohai Biological Technology Co Ltd (5HB) under the Base Case is 2.56 EUR.

Is 5HB stock undervalued or overvalued?

Compared with the current market price of 1.79 EUR, the stock appears Undervalued by 30% .

How reliable are our estimates? See how past valuations played out
Back to Top